Stockreport

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript [Seeking Alpha]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF Company Participants Matthew Goldberg - Senior Vice President of Medical Camilla Zuckero - Vice President of Investor Relations & Corporate Affairs Derek Maetzold [Read more]